A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
Clinical trial NCT03006068 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03006068
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2027-07-01
- Enrollment
- 950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.